跳至主要内容
临床试验/DRKS00033108
DRKS00033108已完成Unknown

Release of X-Pro dipeptides and amino acids from stable isotope-labelled gluten-related immunogenic peptided by AMY01 - AMY01-POC

niversitätsmedizin Greifswald0 个研究点目标入组 16 人开始时间: 2023年11月28日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 55 Years(—)
性别
All

入选标准

  • understands the study purpose and design
  • - contractually capable and provides signed informed consent form
  • - healthy condition or mild and/or well treated forms of allergies, asthma,
  • hypertension, and orthopedic diseases

排除标准

  • a.BMI > 35 kg/m2 and <18 kg/m2
  • b.known pregnancy or lactation period
  • c.women: positive urine pregnancy test at screening or visit
  • d.anemia (Hb < 13 g/dl (8,07 mmol/l) in men or < 12 g/dl (7,45 mmol/l)
  • e.blood donation within the last 4 weeks
  • f.elevated liver function tests (ALAT, ASAT, yGT, Bilirubin > 2x ULN)
  • g.reduced renal function (eGFR MDRD < 60 ml/min/1,7m2)
  • h.known history of celiac disease or gluten intolerance
  • i.known gastrointestinal disease
  • j.intake of proton pump inhibitors
  • k.prescription of > 2 drugs taken during the screening and study visits
  • l.psychiatric disease or drug dependency
  • m.use of recreational drugs more than twice a week
  • n.poor venous conditions that make it impossible to place a peripheral
  • venous catheter and regularly draw blood through it

研究者

发起方
niversitätsmedizin Greifswald

相似试验